Courriel : bd@sidmexinovia.com
Téléphone : +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Lenvanamo 10mg Capsule
Manufacturer/Marketed By : SHIVNAAM TRADELINK LLP
$122.68 $49.07
Lenvanamo 10mg Tablet is composed of the active ingredient Lenvatinib. It is a tyrosine kinase inhibitor indicated for progressive or advanced thyroid cancer when radioactive iodine therapy is not beneficial....
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
LENVATINIB
Active Pharmaceutical Ingredient
Lenvanamo 10mg Capsule
122,68 $US
49,07 $US
Lenvanamo 10mg Tablet is composed of the active ingredient Lenvatinib. It is a tyrosine kinase inhibitor indicated for progressive or advanced thyroid cancer when radioactive iodine therapy is not beneficial. It is also used to treat previously untreated liver cancer patients who are not eligible for surgical treatment. Anaplastic Thyroid Carcinoma (Advanced thyroid cancer) usually occurs in patients above 60 years of age. It is characterized by an enlarged and hard thyroid gland and hoarseness in the voice due to paralysis of the nerve in the voice box. Hepatocellular carcinoma (liver cancer) develops due to preexisting liver conditions such as cirrhosis or chronic hepatitis B infection. Patients who have had an allergic reaction to Lenvanamo 10mg Tablet or any of its components should not take this medication. Patients should inform their dentist or oral surgeon that they are taking Lenvanamo 10mg Tablet, as it can impair wound healing and increase the risk of bleeding.
Active Pharmaceutical Ingredient
Uses
• Certain types of advanced thyroid cancer
• Advanced Liver cancer
• Certain types of kidney cancer
• Endometrial cancer
Benefits
Lenvanamo 10mg Tablet blocks the enzyme receptor tyrosine kinases (RTKs). RTKs develop new blood vessels that supply oxygen and nutrients to the cells and help them grow. This medicine inhibits the receptors that facilitate the growth of blood vessels in tumour cells. RTKs are present in high concentrations in cancer cells, and administration of this medicine slows down the rate of cancer cells’ growth and multiplication.
Side Effects
Like all medications, Lenvanamo 10mg Tablet can cause side effects, although not everyone who takes it will experience them.
Most Common Side Effects
• Fatigue
• Loss of appetite
• Weight loss
• Nausea and vomiting
• Diarrhea
• Stomach pain or discomfort
• Hypertension (high blood pressure)
• Headache
• Joint pain or muscle pain
• Changes in taste
Common Side Effects
• Liver toxicity or liver failure
• Heart problems, such as heart attack
• Hemorrhage (bleeding)
• Blood clots
• Poor wound healing
• Kidney failure
• Hypothyroidism
• Skin reactions (rash or blisters)
How To Use
Lenvanamo 10mg Tablet is an oral medication that is usually taken once a day, at approximately the same time each day, with or without food. It should be taken as prescribed by a doctor or other healthcare provider. These capsules should be swallowed whole with a glass of water. They should not be crushed, chewed, or opened, as this can affect the way the medication is absorbed and decrease its effectiveness. You should not take a double dose to make up the second dose.
Safety Advice
• Breast Feeding: Breastfeeding is not recommended while taking Lenvanamo 10mg Tablet, as it can potentially harm the nursing infant.
• Alcohol: It is recommended to avoid consuming alcohol while taking Lenvanamo 10mg Tablet, as alcohol can increase the risk of certain side effects associated with the medication, such as stomach ulcers or gastrointestinal bleeding.
• Liver: Lenvanamo 10mg Tablet is primarily metabolized in the liver, so inform your healthcare provider if you have any liver problems or diseases. This medication may also increase liver enzymes, which can be a sign of liver damage or inflammation. Patients taking this medication require regular blood tests to monitor liver function.
• Lungs: Lenvanamo 10mg Tablet can cause side effects that affect the lungs, such as cough, shortness of breath, and difficulty breathing. If a person experiences any of these symptoms while taking it, they should notify their healthcare provider right away.
• Driving: Patients receiving Lenvanamo 10mg Tablet should be advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
• Pregnancy: Lenvanamo 10mg Tablet is unsafe during pregnancy as it can cause fetal harm. It is s recommended to avoid this medication during pregnancy.
Disclaimer
Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.
Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.
Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.
Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.